FRPH vs WELL vs GMRE vs PLD vs VTR

For growth investors, Welltower Inc.

(WELL) is the stronger pick with 35. 8% revenue growth year-over-year, versus -1. 8% for Global Medical REIT Inc. (GMRE). Prologis, Inc. (PLD) offers the better valuation at 35. 5x trailing P/E (41. 4x forward), making it the more compelling value choice. Analysts rate Welltower Inc. (WELL) a "Buy" — based on 34 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Prologis, Inc.

(PLD) is the cheapest at 35. 5x versus Ventas, Inc. at 160. 3x. On forward P/E, FRP Holdings, Inc. is actually cheaper at 17. 6x — notably different from the trailing picture, reflecting expected earnings growth.

Over the past 5 years, Welltower Inc.

(WELL) delivered a total return of +202. 3%, compared to -26. 4% for FRP Holdings, Inc. (FRPH). Over 10 years, the gap is even starker: GMRE returned +308. 1% versus FRPH's +26. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Ventas, Inc.

(VTR) is the lower-risk stock at 0. 01β versus Prologis, Inc. 's 0. 73β — meaning PLD is approximately 7596% more volatile than VTR relative to the S&P 500. On balance sheet safety, FRP Holdings, Inc. (FRPH) carries a lower debt/equity ratio of 38% versus 118% for Global Medical REIT Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Welltower Inc.

(WELL) is pulling ahead at 35. 8% versus -1. 8% for Global Medical REIT Inc. (GMRE). On earnings-per-share growth, the picture is similar: Ventas, Inc. grew EPS 184. 2% year-over-year, compared to -94. 6% for Global Medical REIT Inc.. Over a 3-year CAGR, WELL leads at 22. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Prologis, Inc.

(PLD) is the more profitable company, earning 45. 5% net margin versus 4. 3% for Ventas, Inc. — meaning it keeps 45. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: PLD leads at 53. 8% versus 3. 3% for WELL. At the gross margin level — before operating expenses — FRPH leads at 91. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, FRP Holdings, Inc.

(FRPH) trades at 17. 6x forward P/E versus 595. 7x for Global Medical REIT Inc. — 578. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for GMRE: 11. 9% to $40. 00.

In this comparison, GMRE (63.

5% yield), PLD (2. 6% yield), VTR (2. 1% yield), WELL (1. 3% yield) pay a dividend. FRPH does not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Ventas, Inc.

(VTR) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 01), 2. 1% yield). Both have compounded well over 10 years (VTR: +65. 0%, FRPH: +26. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Real Estate sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: FRPH is a small-cap quality compounder stock; WELL is a mid-cap high-growth stock; GMRE is a small-cap income-oriented stock; PLD is a mid-cap quality compounder stock; VTR is a mid-cap high-growth stock. WELL, GMRE, PLD, VTR pay a dividend while FRPH does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.